Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients
- Status
- TERMINATED
- Phase
- PHASE2
Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis
- Status
- UNKNOWN
- Phase
- N/A
Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study
- Status
- TERMINATED
- Phase
- PHASE4
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
- Status
- COMPLETED
- Phase
- PHASE2
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- N/A
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
- Status
- COMPLETED
- Phase
- PHASE3
Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC SYNDROMES
- Status
- UNKNOWN
- Phase
- N/A
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza
- Status
- COMPLETED
- Phase
- PHASE1
Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML
- Status
- UNKNOWN
- Phase
- PHASE1
Nonmyeloablative Allogeneic Transplant
- Status
- COMPLETED
- Phase
- NA
Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)
- Status
- UNKNOWN
- Phase
- N/A
Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
- Status
- UNKNOWN
- Phase
- N/A
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers
- Status
- UNKNOWN
- Phase
- PHASE2